期刊文献+

野生型DNA聚合酶β重组绿色荧光蛋白表达载体的构建 被引量:3

Construction of the enhanced green fluorescent protein eukaryotic expression vector carrying wild type DNA polymerase β gene
下载PDF
导出
摘要 目的:构建携带野生型DNA聚合酶β基因(wtDNApolβ)的重组真核绿色荧光蛋白表达载体pEGFP-C3-polβ。方法:运用PCR方法,从质粒pcDNA3.1-polβ中扩增出wtDNApolβ的开放阅读框序列,T-A克隆至pGEM-T载体,再定向克隆至pEGFP-C3,重组质粒pEGFP-C3-polβ用限制性内切酶酶切鉴定,通用鉴定引物PCR扩增鉴定,并进行DNA序列分析。结果与结论:多种鉴定方法证实了重组载体pEGFP-C3-polβ中的wtDNApolβ序列与GenBank中已知的序列相符。携带wtDNApolβ的重组增强型绿色荧光蛋白表达载体pEGFP-C3-polβ构建成功。 Aim: To construct a recombined enhanced green fluorescent protein vector carrying wild type DNA polymerase β gene(polβ). Methods: The fragment of wild type DNA polβ gene was amplified using PCR from plasmid pcDNA3.1-pol β to be a template and cloned to pGEM-T vector by T-A clone method and then inserted into eukaryotic expression vector pEGFP-C3. The recombined plasmid was identified using restricted enzyme analyzing, PCR technique and sequencing. Results and Conclusion: It is proved that the wild type fragment inserted into pEGFP-C3 is identical with the known fragment. The wild type pEGFP-C3-polβ is successfully constructed.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2005年第4期590-592,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目39870287 教育部科学技术研究重点项目02088
关键词 DNA聚合酶Β 增强型绿色荧光蛋白 DNA序列分析 DNA polymerase β enhanced green fluorescent protein DNA sequence analysis
  • 相关文献

参考文献6

  • 1董子明.DNA聚合酶β的研究现状[J].郑州大学学报(医学版),2003,38(4):477-480. 被引量:13
  • 2Dcormack BP,Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorecent protein (GFP). Gene, 1996,173(1) :33
  • 3Ormo M,Cubitt AB, Kallio K,et al. Crystal structure of the Aequorea victoria green fluorescent pritein. Science, 1996,273(5280):1 392
  • 4赵勤,赵国强,刘康栋,刘栋,金戈,赵继敏,董子明.重组克隆PCR扩增快速筛选方法的建立[J].郑州大学学报(医学版),2003,38(4):486-487. 被引量:1
  • 5Miller BA, Barber DL, Bell LL, et al. Identification of the erythropoietin receptor domain required for calcium channel activation. Bio Chem, 1999, 274 (29) :20 465
  • 6Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Research, 1987,15 (20):8 125

二级参考文献33

  • 1Earl PL, Jones EV, Moss B. Homology between DNA Polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA Polymerase gene. Mol Biol Rep, 1991,15(1) :25.
  • 2Matsukage A, Nishikawa K, Ooi T,et al. Homology between mammalian DNA Polymerase beta and terminal deoxynucleotidyltransferase. J Biol Chem, 1987,262(19) :8960.
  • 3Ergerheim USE, Kunimi K, Collins VP, et al. Deletion mapping on chromosomes8,10 and 16 im human prostatic carcinoma. Gene Chromosom Cancer, 1991,3:215.
  • 4Wang LM,Patel U,Ghosh L,et al. DNA polymerase β mutation in human colorectal cancra. Cancer Res, 1992,52(17):482.
  • 5Emi M, Fujiwara Y, Nakajima T, et al. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res, 1992,52(19) :5368.
  • 6Doboshi Y, Shum T,Tsurga H,et al. DNA polymerase β gene mutation in human prostate cancer. Cancer Res, 1994,54(9) :2827.
  • 7Yan ZJ, Roy D. Mutations in DNA Polymerase beta mRNA of stilbene estrogen-induced kidney tumors in Syrian hamster,Biochem. Mol Biol Int, 1995,37 : 175.
  • 8Eydmann ME, Knowles MA. Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer. Cancer Genet Cytogenet, 1997,93(2) : 167.
  • 9Dib A, Adelaide J, Chaffanet M, et al. Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma. Oncogene, 1995,10(5) : 995.
  • 10SenGupta DN, Zmudzka BZ, Kumar P, et al. Sequence of human DNA polymerase beta mRNA obtained through cDNA cloning. Biochem Biophys Res Commun, 1986,136(1) :341.

共引文献12

同被引文献26

  • 1张燕,金先庆,赵珍珍,宿玉玺.5种耐药基因在成人常见恶性肿瘤中的表达特点[J].重庆医科大学学报,2007,32(10):1023-1026. 被引量:16
  • 2YANG L Y,TRUJILLO J M.Biological characterization of multi-drug-resistant human colon carcinoma sublines induced/selectedby two methods[J].Cancer Res,1990,50(11):3218-3225.
  • 3MIMEAULT M,HAUKE R,BATRA S K.Recent advances on themolecular mechanisms involved in the drug resistance of cancercells and novel targeting therapies[J].Clin Pharmacol Ther,2008,83(5):673-691.
  • 4KIMURA Y,MORITA S Y,MATSUO M,et al.Mechanism ofmultidrug recognition by MDR1/ABCB1[J].Cancer Sci,2007,98(9):1303-1310.
  • 5AKIYAMA S.Mechanisms of drug resistance and reversal of theresistance[J].Hum Cell,2001,14(4):257-260.
  • 6GOTTESMAN M M.Mechanisms of cancer drug resistance[J].Annu Rev Med,2002,53:615-627.
  • 7IDRISS H T,AL ASSAR O,WILSON S H.DNA polymerase beta[J].Int J Biochem Cell Biol,2002,34(4):321-324.
  • 8MATSUDA T,BEBENEK K,MASUTANI C,et al.Low fidelityDNA synthesis by human DNA polymerase-beta[J].Nature,2000,404(6781):1011-1013.
  • 9CANITROT Y,CAZAUX C,FRCHET M,et al.Overexpressionof DNA polymerase beta in cell results in a mutator phenotype anda decreased sensitivity to anticancer drugs[J].Proc Natl Acad SciU S A,1998,95(21):12586-12590.
  • 10BERGOGLIO V,CANITROT Y,HOGARTH L,et al.Enhancedexpression and activity of DNA polymerase beta in human ovariantumor cells:impact on sensitivity towards antitumor agents[J].Oncogene,2001,20(43):6181-6187.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部